US2016346424A1PendingUtilityA1
Adhesive compounds and methods use for hernia repair
Est. expiryNov 9, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Bruce P. LeeJeffrey L. DalsinJohn L. MurphyLaura VollenweiderArinne LymanFangmin XuJediah WhiteWilliam D. LewMichael Brodie
A61L 24/001A61L 24/0005C09J 171/02A61L 24/046A61F 2/0063A61L 24/043A61L 24/06
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention describes new synthetic medical adhesives and films which exploit the key components of natural marine mussel adhesive proteins.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A construct, comprising an adhesive compound and a support wherein said adhesive compound is a multi-hydroxyl phenyl derivative polymer, a multi-methoxy phenyl derivative polymer, a combination multi-hydroxyl and multi-methoxy phenyl derivative polymer, a mono-methoxy and mono-hydroxyl phenyl derivative polymer or a combination thereof wherein said adhesive compound is p(CL1.25kEG10kb-g-DH2), p(CL2kGEG10kb-g-DMu2), p(CL1.25kEG10kb-g-DMu2), p(CL5.6kEG10kb-g-DH2), p(LA4.2kEG10kb-g-DH2), p(CL2kEG10k(SA)b-g-DMe2, p(CL1.25kEG10k(SA)b-g-DMe2), p(CL2kEG1Okb-g-MTu2), p(CL2kEG10kb-g-DMPAu2), p(CL2kEG10k(GA)b-g-DMe2), p(CL2kEG10k(GABA)b-g-DHe2), p(CL2kEG10k(GABA)b-g-HFe2), p(CL2kEG10k(GABA)b-g-DMHCAe2), p(CL2kEG10k(GA)b-g-MTe2)or a combination thereof.
2 . The construct of claim 1 , wherein said construct is configured to be affixed to a subject having a hernia.
3 . The construct of claim 2 , wherein said hernia is a congenital hernia, an acquired hernia, an inguinal hernia, an indirect inguinal hernia, a direct inguinal hernia, a saddle bag hernia, a sliding hernia, an umbilical hernia, a paraumbilical hernia, an incisional hernia, a ventral hernia, a femoral hernia, a Copper's hernia, an epigastric hernia, a Spigelian hernia, a semilunar hernia, a Littre's hernia, a Richter's hernia, a lumbar hernia, a sciatic hernia, a sports hernia, an Amyand's hernia, an anal hernia, a Maydl hernia, a hiatus hernia, a diaphragmatic hernia, a paraesophageal hernia, a perineal hernia, a properitoneal hernia, a mesenteric hernia, an intraparietal hernia, a bilateral hernia, a complicated hernia, an incarcerated hernia, a strangulated hernia, an uncomplicated hernia, a complete hernia, an incomplete hernia, an intracranial hernia, an internal hernia, an external hernia or a combination thereof.
4 . The construct of claim 1 , wherein said adhesive compound is a liquid, a coating or a film.
5 . The construct of claim 1 , wherein said polymer is polyethylene glycol (PEG) polymer, a polycaprolactone (PCL) polymer, a polylactic acid (PLA) polymer, a polyester polymer, a multiblock polymer or combination thereof.
6 . The construct of claim 1 , wherein said adhesive compound degrades at a predetermined rate.
7 . The construct of claim 1 , wherein said adhesive compound is activated in situ.
8 . The construct of claim 7 , wherein said adhesive compound is activated by water, by saline, by at least one bodily fluid, by temperature, by pH, or by pressure.
9 . The construct of claim 1 , wherein said adhesive compound comprises an oxidant.
10 . The construct of claim 9 , wherein said oxidant is embedded within said adhesive compound.
11 . The construct of claim 9 , wherein said oxidant is applied to said adhesive compound by spraying, brushing or dipping or a combination thereof.
12 . The construct of claim 1 , wherein said support comprises an adhesive compound polymer, a film polymer, a scaffold, a membrane, a graft, an implant, a mesh or a combination thereof.
13 . The construct of claim 1 , wherein said support is a synthetic support or a biologic support.
14 . The construct of claim 13 , wherein said synthetic support comprises a polypropylene support, a polyester support, a condensed polytetrafluoroethylene (cPTFE) support, an expanded polytetrafluoroethylene (cPTFE) support, a polycarbonate polyurethane-urea support, a copolymer of polyglycolide, polyactide and polytrimethylene support, a copolymer polyactide support, a polytrimethylene carbonate support, a polylactic acid (PLA) support, a tyrosine polyarylate support, a polydroxyalkanoate support, a silk-elastin polymer support or a combination thereof.
15 . The construct of claim 13 , wherein said biologic support comprises a dermis support, a human-derived dermis support, a porcine-derived dermis support, a bovine-derived dermis support, a collagen-containing matrix support, an engineered dermis support, a pericardium support, an extracellular matrix support, or a small intestine submucosa support.
16 . The construct of claim 1 , wherein said adhesive compound is coated on said support in a predetermined pattern.
17 . The construct of claim 16 , wherein said pattern comprises at least one region coated with said adhesive compound and at least one region not coated with said adhesive compound.
18 . The construct of claim 2 , wherein said affixing comprises a tissue adhesive, a suture, a staple, a tack or a combination thereof.
19 . The construct of claim 1 , wherein said construct comprises an adhesive compound on at least one surface of said support, and a non-adhesive compound on at least one surface of said support.
20 . The construct of claim 19 , wherein said non-adhesive compound comprises an anti-adhesive compound.
21 . The construct of claim 19 , wherein said non-adhesive compound comprises an oxidant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.